135
clinicians, but often causes operation difficulties because of vas-
cular variation. Thus sometimes anteromedial thigh was used as
new donor site temporarily when the vascular anatomic variation
of anterolateral thigh perforator flap induced a failure in the flap
harvest.
Objectives:
To discuss the anatomy and application of anterome-
dial thigh flap in 13 cases.
Methods:
We collect 13 cases of the anteromedial thigh flap trans-
plantation during 2009 to 2015. Seven of them were elected due to
the error of the ultrasonic test, three of them were elected because
of the diameter being too small, other three cases were elected due
to the failure of iatrogenic behaviours.
Findings and Conclusions:
Seven of the cases had vessels
directly to the skin, six of them were intramuscular perforators.
10 of the cases were bilobate flaps, and three of them were folding
flaps. All of the 13 cases survived with no vascular crisis occurring.
The follow-up results after three to six months were satisfactory.
http://dx.doi.org/10.1016/j.ijom.2017.02.468The role of molecular targeted therapy in the management of
oral cavity squamous cell carcinoma
S. Thambar
∗
, J. Yaxley, D. Nikolarakos
Department of Oral and Maxillofacial Surgery, Gold Coast
University Hospital, Queensland, Australia
Oral cavity squamous cell carcinoma (OC-SCC) is a common
malignancy of the head and neck region and a major cause of
morbidity and mortality worldwide. It is an aggressive condition
associated with a poor survival rate for late-stage disease, and a
high rate of reoccurrence. The carcinogenesis of OC-SCC involves
a complex sequence of molecular events, and gene studies have
aided in the development of a genetic progression model for the
condition.
Treatment options are multimodal, with surgery, radiation and
chemotherapy, depending on the TNM cancer staging. Molecular
targeted therapy is an emerging treatment for advanced OC-SCC
involving targeting specific molecular alterations of a cancer cell
that contributes to the neoplastic phenotype. These include growth
factors and their receptors, signal transduction molecules, onco-
genes, apoptosis-related molecules, angiogenesis-related factors,
as well as inhibitors of cell motility, invasion, and proteolysis. The
treatment offers a higher therapeutic index and is associated with
less toxicity than cytotoxic drugs.
This presentation will review potential molecular targets in
OC-SCC, include those related to growth regulation (epidermal
growth factor receptor), angiogenesis (vascular endothelial growth
factor), and inflammation (cyclooxygenase-2). It will also analyse
current and emerging agents for molecular targeted therapy with
evidence based data and statistic results. A better understanding
of the molecular basis of OC-SCC aids in the selection of a tar-
geted treatment, and ultimately improves outcomes of patients
with advanced disease.
http://dx.doi.org/10.1016/j.ijom.2017.02.469Access to the infratemporal and pterygopalatine fossae — a
new modified transfacial technique combined with
mandibular ramus osteotomy
K. Tzanidakis
∗
, N. Kalavrezos, Z. Sadiq
University College London Hospitals NHS Foundation Trust,
London, England, United Kingdom
Background:
Access to the infratemporal and pterygopalatine
fossae has been historically described by the Fisch approaches (A,
B, C, D). Other authors have reported modifications of those tech-
niques with the aim to balance aesthetics and sacrifice of important
structures such as the facial nerve. Recently less invasive endo-
scopic techniques have been proposed, but the surgical objective
is of palliation rather than curative intent.
Objectives:
The authors attempted to identify amethod that would
provide a generous surgical access to the area for the purposes of
an oncological procedure while ensuring a good cosmetic result
with preservation of the important structures such as the facial
nerve.
Methods:
We report a new technique that combines a Weber-
Ferguson transfacial approach and a vertical osteotomy or
ostectomy of the anterior part of the ramus of the mandible. We use
the experience from two patients that presented with malignancy
of the infratemporal and pterygopalatine fossae.
Findings:
The implementation of this new approach has achieved
the primary objectives set by the authors during the planning stage
of the procedure; complete clearance of the malignancy was estab-
lished, an acceptable aesthetic result was acknowledged and the
facial nerve was preserved.
Conclusion:
The nature of the surgical practice is to pursuit new
techniques that will offer to our patients a good quality of life; espe-
cially in this modern era any salvage surgery must account for an
acceptable aesthetic and functional outcome for the patients. This
new technique has shown promising results in that perspective.
http://dx.doi.org/10.1016/j.ijom.2017.02.470Bone invasion by oral squamous cell carcinoma: essential
molecular alterations
L.A.A. Vaassen
∗
, E.J.M. Speel, P.A.W.H. Kessler
Maastricht UMC+, The Netherlands
Oral squamous cell carcinoma (OSCC) is a globally growing
problem with 300,000 new cases each year. The close anatomical
relation of the oral mucosa to the jaws often leads to invasion of
the bone, implicating extensive resections with major implications
on function, aesthetics and quality of life.
Planning of bony resections depends on two staging methods:
(1) clinical estimation by the surgeon and (2) radiological imag-
ing. Unfortunately both methods have their shortcomings. Most
important step in bone invasion is activation of osteoclasts. Abetter
understanding on molecular alterations leading to osteoclastoge-
nesis is of great importance. The presence of teeth and infections
in the oral cavity, and hypoxia in the tumour microenvironment
could have a key role.
We propose that reprogramming energy metabolism and
tumour promoting inflammation also play an important role in
detecting molecular biomarkers associated with bone invasion by
OSCC. Improvement in the understanding of these molecular pro-




